KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 162 filers reported holding KRYSTAL BIOTECH INC in Q1 2023. The put-call ratio across all filers is 1.80 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $483,836 | +0.1% | 4,171 | +1.3% | 0.02% | 0.0% |
| Q2 2023 | $483,453 | -62.5% | 4,118 | -74.4% | 0.02% | -62.8% |
| Q1 2023 | $1,289,366 | +1.0% | 16,105 | -0.1% | 0.04% | -21.8% |
| Q4 2022 | $1,277,185 | -14.2% | 16,122 | -24.5% | 0.06% | -20.3% |
| Q3 2022 | $1,489,000 | +6.5% | 21,358 | +0.3% | 0.07% | +7.8% |
| Q2 2022 | $1,398,000 | -14.9% | 21,284 | -13.4% | 0.06% | -1.5% |
| Q1 2022 | $1,643,000 | -31.0% | 24,565 | -27.8% | 0.06% | -26.1% |
| Q4 2021 | $2,381,000 | +735.4% | 34,036 | +524.1% | 0.09% | +700.0% |
| Q3 2021 | $285,000 | -23.2% | 5,454 | 0.0% | 0.01% | -31.2% |
| Q2 2021 | $371,000 | -11.7% | 5,454 | 0.0% | 0.02% | -20.0% |
| Q1 2021 | $420,000 | +28.4% | 5,454 | 0.0% | 0.02% | +11.1% |
| Q4 2020 | $327,000 | +39.1% | 5,454 | 0.0% | 0.02% | +20.0% |
| Q3 2020 | $235,000 | +4.4% | 5,454 | 0.0% | 0.02% | 0.0% |
| Q2 2020 | $225,000 | – | 5,454 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 771,250 | $53,949,000 | 4.15% |
| First Light Asset Management, LLC | 680,170 | $47,578,000 | 3.41% |
| ACT CAPITAL MANAGEMENT, LLC | 59,000 | $4,127,000 | 2.98% |
| S Squared Technology, LLC | 95,215 | $6,660,000 | 2.98% |
| Redmile Group, LLC | 1,820,898 | $127,372,000 | 2.90% |
| Soleus Capital Management, L.P. | 228,437 | $15,979,000 | 1.60% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 50,922 | $3,562,000 | 1.59% |
| Artal Group S.A. | 700,000 | $48,965,000 | 1.33% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 46,670 | $3,265,000 | 1.32% |
| Kynam Capital Management, LP | 34,816 | $2,435,000 | 1.30% |